Jim Keon, president of the Canadian Generic Pharmaceutical Association, issued a statement: “The CGPA and its member companies support efforts to improve prescription drug coverage for Canadians,” he said. “While CGPA supports efforts to improve prescription drug coverage, governments must also ensure that Canadians have a more secure supply of prescription medicines by supporting enhanced domestic production capacity … Read more
Jim Keon, President of the Canadian Generic Pharmaceutical Association, issued a statement: “The CGPA welcomes the federal government’s recognition that a stronger life sciences sector and vaccine production can contribute to a more resilient Canada and healthier Canadians,” he said. “While CGPA is supportive of the proposed financial investments intended to strengthen Canada’s life sciences sector, this … Read more
Jim Keon, President of the Canadian Generic Pharmaceutical Association, issued a statement: “The Trump Administration and House Democrats announced they have reached an agreement on CUSMA, including several improvements to the pharmaceutical intellectual property aspects of the agreement. The CGPA expects that such improvements are included in the revised CUSMA signed today by Canada, the United States and Mexico. … Read more
Jim Keon, President of the Canadian Generic Pharmaceutical Association, issued a statement: “The Canadian Generic Pharmaceutical Association and its member companies welcome the announcement in Budget 2019 that the Government of Canada intends to move forward with measures outlined in the interim report from the Advisory Council on the Implementation of National Pharmacare,” he said. “The … Read more
A new poll confirms that Canadians do not want their access to generic and biosimilar medicines traded away under a new NAFTA deal. “This poll confirms that Canadians do not support any concessions in a new NAFTA that will delay their access to more affordable generic and biosimilar medicines,” said Jim Keon, President of the Canadian … Read more
Director general of the European Generic medicines Association Greg Perry and president of the Canadian Generic Pharmaceutical Association Jim Keon issued a joint statement on the negotiations for a Comprehensive Economic and Trade Agreement (CETA) between the European Union and Canada. Keon said the generic pharmaceutical industry is a strong advocate for enhanced trade, and … Read more
President of the Canadian Generic Pharmaceutical Association Jim Keon issued a statement regarding Canada’s admission to the Trans-Pacific Partnership negotiations. Keon said the Canadian Generic Pharmaceutical Association congratulates the Government of Canada on formally joining the Trans-Pacific Partnership negotiations. Keon added that as an industry that is heavily dependent on trade, generic pharmaceutical manufacturers support … Read more
President of the Canadian Generic Pharmaceutical Association Jim Keon issued a statement regarding the latest round of negotiations for a Comprehensive Economic and Trade Agreement between Canada and the European Union (EU), which begin in Ottawa. Keon said Canada’s generic pharmaceutical industry is the country’s primary source of pharmaceutical manufacturing and exports, and employs more … Read more
The Canadian Generic Pharmaceutical Association issued a statement regarding the drug shortages in Canada. The association announced their commitment and financial support in responding urgently to prescription drug shortages. President of the association Jim Keon said that the association members understand the anxiety and frustration that drug shortages cause Canadian patients, their families and healthcare … Read more
